Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists (DOLOREPIT)

Centre Hospitalier Emile Roux

Status

Enrolling

Conditions

Chronic Pain

Treatments

Other: Standard pain management combined with sleep disorder management

Study type

Interventional

Funder types

Other

Identifiers

NCT06052384

RIPH2_PEREZ_DOLOREPIT

2022-A00919-34 (Other Identifier)

Details and patient eligibility

About

DOLOREPIT is an interventional, RIPH 2, multicenter, randomized, controlled, open-label study comparing two care pathways for the management of patients with chronic pain.

Enrollment

664 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

First consultation at the pain management center
Patient with chronic pain as defined by the "Haute Autorité de Santé". The pain must have several of the following characteristics:
- Persistence or recurrence
- Duration beyond what is usual for the presumed initial cause, especially if the pain has been evolving for more than 3 months;
- Inadequate response to treatment;
- Important and progressive deterioration of the patient's functional and interpersonal abilities in activities of daily living at home, school, or work due to the pain.
Patients with chronic primary pain (according to the typology defined by the International Classification of Diseases-11) and classified into one of the 4 following categories:
- Chronic generalized pain
- Complex regional pain syndrome
- Chronic primary headache or orofacial pain
- Chronic primary musculoskeletal pain
Pittsburgh Sleep Quality Index (PSQI) must be completed by the patient and the score must be available (for randomization purposes)
Have access to an internet connection as a self-administered questionnaire is to complete online, and at least have access to the online platform for CBT treatment if insomnia is detected
Affiliation to a French social security system
Free informed consent

Exclusion criteria

Patients undergoing cancer treatment or who have completed treatment within the last 2 years
Patient with a chronic inflammatory disease (e.g. rheumatoid arthritis, ankylosing spondylitis, chronic inflammatory bowel disease, Horton's disease, Wegener's disease, myositis, Still's disease, lupus erythematosus, etc.)
Immunocompromised patient
Patient with severe psychiatric pathology that does not allow study follow-up (at the discretion of the investigator)
Patient already treated for a sleep disorder by a sleep specialist (the only prescription of hypnotics is not considered as a criterion of non-inclusion)
Patient follow-up difficult (for geographic motives or other reasons)
Patient under judicial protection of incapable adults or guardianship
Refusal to participate in the research